IFNG and COVID-19: We indeed observed that the CoronaVac-vaccinated study participants had noticeably higher levels of anti-SARS-CoV-2 S-RBD antibodies and T cell-derived IFN-γ compared to the ones who did not receive COVID-19 vaccination.